Low dose oral administration of 4-demethoxy-daunorubicin (idarubicin) in advanced cancer patients
Cancer Chemotherapy and Pharmacology(1986)
Abstract
Data relating to 4-demethoxydaunorubicin (DMDR) pharmacokinetics after oral administration (10–15 mg/m2 per day for 3 days) were collected in a total of 12 patients with advanced breast cancer and melanoma.
MoreTranslated text
Key words
Breast Cancer, Melanoma, Doxorubicin, Oral Administration, Urinary Excretion
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined